Principal Financial Group Inc. Sells 17,945 Shares of National Health Investors, Inc. $NHI

Principal Financial Group Inc. decreased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 1.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,637,038 shares of the real estate investment trust’s stock after selling 17,945 shares during the period. Principal Financial Group Inc.’s holdings in National Health Investors were worth $130,145,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewEdge Advisors LLC raised its position in National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after buying an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after buying an additional 21,851 shares in the last quarter. Jane Street Group LLC grew its position in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of National Health Investors by 11.0% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 4,009 shares of the real estate investment trust’s stock worth $284,000 after acquiring an additional 398 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in shares of National Health Investors by 267.4% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,508 shares of the real estate investment trust’s stock valued at $316,000 after buying an additional 3,281 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on NHI shares. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a report on Monday, January 5th. Wells Fargo & Company boosted their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. National Bankshares set a $85.00 price target on shares of National Health Investors in a research note on Tuesday, January 20th. KeyCorp raised their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a research report on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and an average price target of $85.57.

National Health Investors Price Performance

Shares of NYSE NHI opened at $80.42 on Tuesday. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74. The stock has a market cap of $3.83 billion, a price-to-earnings ratio of 25.37, a PEG ratio of 2.81 and a beta of 0.66. The company’s 50-day moving average price is $78.34 and its 200 day moving average price is $76.76. National Health Investors, Inc. has a 52 week low of $65.22 and a 52 week high of $82.39.

National Health Investors (NYSE:NHI) last announced its earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. The firm had revenue of $83.36 million for the quarter, compared to analysts’ expectations of $85.66 million. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.National Health Investors’s quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st were issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date was Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is 116.09%.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.